New standards from the National Cholesterol Education Program's committee on cholesterol, published this week in the Journal of the American Medical Association, recommend that anyone with symptomatic peripheral or carotid artery conditions and LDL levels of above 130 should be on therapy to help reduce their cholesterol levels. Those with multiple risk factors such as high blood pressure, diabetes or who smoke should try dietary changes to help reduce their cholesterol levels. These new standards affect nearly one out of five adults living in the U.S. and if strictly followed, could nearly triple the number of patients recommended for cholesterol-lowering medications. One tablet will contain Vitamin C for added health benefits, and the other will combine Manapol powder with bran. Studies have shown that oat bran may be beneficial in helping to keep a healthy cholesterol level.
Formal launch is planned for late summer.
Carrington has received patents in the U.S. and European Union for the use of certain of its complex carbohydrates in lowering and regulating cholesterol and removing plaque from blood vessels. Inc. All Rights Reserved.